Navigation Links
Avomeen's cGMP Pharmaceutical Laboratory Develops New Methods & Allocates Analytical Chemistry Resources to Investigate Compounding Pharmacy Products
Date:6/4/2013

Ann Arbor, Michigan (PRWEB) June 04, 2013

Since last fall’s deadly meningitis outbreak, Avomeen's pharmaceutical testing laboratory has dedicated new resources and developed new methods for the analysis of drugs from compounding pharmacies.

Compounding pharmacies pose a continued threat to consumers due to a lack of regulation by the Food and Drug Administration. FDA officials have recently released results from an inspection of 30 compounding pharmacies that mix sterile drugs. The results exposed dozens of safety problems including contaminates in the form of unidentified black particles bring found in vials of sterile solutions, rust/ mold within the manufacturing plants and workers being exposing to conditions that would allow their skin to come in contact with chemicals.

Pharmaceuticals mixed in conditions such as those confirmed by the FDA have a higher likelihood of contamination and subsequent detrimental effects when consumed. Avomeen's pharmaceutical testing laboratory answers the need for an independent, FDA-Registered, DEA-Licensed, cGMP-Compliant laboratory to provide accurate and timely analysis of pills, liquids, capsules and more.

Avomeen’s pharmaceutical testing division has bolstered its analytical capabilities by hiring additional senior scientists with backgrounds in areas such as deformulation, stability testing, quality control analysis and contamination identification. Avomeen is dedicated to the analysis of drugs and pills produced from compounding pharmacies.

New and enhanced services include impurity analysis, batch-to-batch testing, degradation profiling, trace metals analysis and contamination quantification. The pharmaceutical analysis staff now has the capability of efficiently and effectively analyzing the output of pills, liquids and drugs from compounding pharmacies. '/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. Roswell Park Cancer Institute, Jasco Pharmaceuticals Join Forces to Advance Development of Anticancer Agent
2. PhenObestin 37.5, a Pharmaceutical Grade Dietary Supplement, Urges Dieters to Lose Weight Without Experiencing Harmful Side Effects
3. Pharmaceutical Pricing and Health Outcomes Top Trending News This Week from HealthEconomics.Com
4. HealthEconomics.Com Launches HE-Xpo, an Online Virtual Trade Show, Educational Center and Exhibit Hall at Major Pharmaceutical Industry Meeting
5. Pharmaceutical advances offer new options for health outcomes
6. Active Pharmaceutical Ingredients (API) Market in Europe Will Reach $38,255.67 Million By 2017- Pricing and Reimbursement Initiatives Supporting Generic Drug Growth
7. Cloud Computing in Pharmaceutical Research and Development - Virtualization of Data through the Cloud Optimizes Next-Generation DNA Sequencing and Clinical Trials Data
8. Aeolus Pharmaceuticals To Present At Taglich Brothers 10th Annual Small Cap Equity Conference
9. TraceLink Leads Pharmaceutical Track and Trace, Big Data and Cloud-based Supply Networks Discussion at LogiPharma Europe Conference
10. Corporate Whistle Blower Center Now Urges Pharmaceutical Insiders Or Physicians To Become A Whistleblower If They Can Prove A Drug Maker Was Knowingly Involved In Bribery
11. Pharmaceutical advertising down but not out
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... DENVER For the first time an oncogenic somatic ... during transfection) protein has been identified in small cell ... mutation within SCLC cell lines produced increased intracellular signaling ... form of lung cancer representing 15% of all lung ... representing 85% of lung cancer, has been extensively examined ...
(Date:8/22/2014)... autoimmune disease that affects 1 to 2 percent ... with pain, disability and joint disfigurements, but also ... and marital functioning. While many pharmacological advances help ... common. In addition, some patients avoid newer medications ... Because of this, there is interest in psychosocial ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 Restore ... Sen and Dr. Samantha Pearson to help people discover ... avoid corrective vision surgery by instead improving their eyesight ... an investigative review. , “There’s a reason why ... in revenue each year—it’s because people just assume that ...
(Date:8/22/2014)... New York (PRWEB) August 22, 2014 ... to be filed in U.S. courts on behalf ... due to their use of prescription low testosterone ... documents, a new claim was filed against Pfizer ... who allegedly suffered life-threatening heart issues due to ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 Mueller Sports ... Plantar Fasciitis, an exciting new product that provides non-drug ... to stay active while you heal. The package includes ... truly a new technology – it is not kinesiology ... FasciaDerm® PFTape™ System for Plantar Fasciitis is ...
Breaking Medicine News(10 mins):Health News:Novel oncogenic RET mutation found in small cell lung cancer 2Health News:Study shows cognitive-behavioral coping skills training has positive effects on rheumatoid arthritis 2Health News:Restore My Vision Today: Review Exposes Natural Eye Restoration Guide by Dr. Sen and Dr. Samantha Pearson 2Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 2Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 3Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 4Health News:Mueller Introduces FasciaDerm® PFTape™ System for Plantar Fasciitis 2
... Inc.,(NYSE: ZMH ; SWX: ZMH), a leader ... participating in Merrill Lynch,s 19th Annual Global,Pharmaceutical, Biotechnology ... 5, 2008, at 8:00 a.m. Eastern Time., ... accessed via Zimmer,s,Investor Relations website at http://investor.zimmer.com ...
... several years of research into the gecko,s uncanny ability to ... have developed an adhesive that is the first to master ... feet. The material could prove useful for a range of ... tape or glue, the new material is crafted from millions ...
... giving radiation, study says , , TUESDAY, Jan. 29 ... gender and medical training, may influence whether a ... a U.S. study suggests. , Many breast ... conservation therapy, even though it,s been shown to ...
... disease , , TUESDAY, Jan. 29 (HealthDay News) -- A man,s ... of sex hormones circulating in his bloodstream, a new British ... of 18 studies -- representing 95 percent of all available ... and blood hormone levels, the study authors said. , "There ...
... Jan. 29 The following statement,was issued today by ... expected spin-off of Philip Morris International as a separate,company, ... greater,variety of deadly and addictive products around the world, ... implement proven measures to,reduce tobacco use and save lives. ...
... Jan. 29 Answering President,Bush,s State of the ... solutions to reform the nation,s retirement programs, the ... Center for Assisted,Living (AHCA/NCAL) and Alliance for Quality ... on this front by taking up long term,and ...
Cached Medicine News:Health News:The pitter patter of little feet... climbing straight up a wall 2Health News:Surgeons' Characteristics Influence Breast Cancer Care 2Health News:Sex Hormones Don't Seem to Affect Prostate Cancer Risk 2Health News:Sex Hormones Don't Seem to Affect Prostate Cancer Risk 3Health News:Philip Morris International Spin-off Should Spur Nations to Take Urgent Action to Reduce Tobacco Use 2Health News:Philip Morris International Spin-off Should Spur Nations to Take Urgent Action to Reduce Tobacco Use 3Health News:Answering Bush SOTU Retirement Reform Challenge, Long Term Care Profession Urges Congress to Enact Bold Reform of Long Term and Post Acute Care Delivery Systems 2
(Date:8/22/2014)... 22, 2014  Mark Riccio, director of Cornell ... is using the online crowd-funding platform Kickstarter to ... to researchers and would-be superheros everywhere: "for FREE." ... YOU do if you had Superman,s X-ray vision?" ... explorers everywhere, from elementary through high school students, ...
(Date:8/22/2014)... 22, 2014  Cannabis Science, Inc. (OTC: CBIS), ... development and related consulting, is pleased to announce ... cannabis conference taking place at the Faculty of ... on October 22, 2014.  The multilingual conference brings ... researchers, health professionals, and patients, to discuss the ...
(Date:8/22/2014)... - SQI Diagnostics Inc. (TSX-V: SQD), a life ... and products for advanced microarray diagnostics, today announced ... Agreement to contract with a UK-based company to ... initial phase of this agreement, SQI will be ... one of the customer,s assays, operational on SQI,s ...
Breaking Medicine Technology:Cornell's X-ray Imaging Lab Director Uses Kickstarter Campaign to "Democratize" Advanced 3D Imaging 2Cannabis Science, Inc. (CBIS) to Sponsor 3rd International Conference on Cannabinoids in Medicine in October 2014 in Strasbourg, France 2Cannabis Science, Inc. (CBIS) to Sponsor 3rd International Conference on Cannabinoids in Medicine in October 2014 in Strasbourg, France 3SQI Diagnostics Contracted to Automate Pathogen Detection Assays 2SQI Diagnostics Contracted to Automate Pathogen Detection Assays 3
... Holdings, Inc. (OTC Bulletin Board: ADLS ), announced ... discussing the Company,s 2010 third quarter financial results on Friday, ... Ph.D., Chairman & Chief Executive Officer, as well as other ... on the Company. A press release reporting the 2010 third ...
... 2010 Neuraltus Pharmaceuticals, a privately held biopharmaceutical ... that address critical unmet needs, primarily in the ... was awarded three grants totaling $733,437 ... (QTDP).  The grants are being provided under section ...
Cached Medicine Technology:Advanced Life Sciences to Host 2010 Third Quarter Financial Results Conference Call and Webcast 2Neuraltus Pharmaceuticals Awarded $733,437 Under the Qualifying Therapeutic Discovery Projects Grant Program (QTDP) 2Neuraltus Pharmaceuticals Awarded $733,437 Under the Qualifying Therapeutic Discovery Projects Grant Program (QTDP) 3
... nerve stimulator from B. Braun Medical. It ... stimulator functionality for over 10 years. , ... a unique, under-the-glove hand held remote current ... It allows the anesthesia provider operating solo ...
... helps you deliver unmatched performance through patient-focused ... the most complete anesthesia solution developed, putting ... - at your fingertips., ,The Aisys ... legacy of anesthesia delivery and patient monitoring ...
... Plug is combining a lightweight mesh material with ... soft hernia plug which stands for a high ... body material is included in Premilene Mesh LP ... allows for a softer and less bulky Plug ...
... Celsius Control System provides physicians,with ... safely,and rapidly lower patient body ... temperature and,rewarm patients to normothermic ... consists of an endovascular,catheter, console ...
Medicine Products: